Cita APA (7a ed.)
Kennedy, S. P., Han, J. Z. R., Portman, N., Nobis, M., Hastings, J. F., Murphy, K. J., . . . Kolch, W. (2019). Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast Cancer Research, 21(1), -1.
Cita Chicago Style (17a ed.)
Kennedy, Sean P., et al. "Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer." Breast Cancer Research 21, no. 1 (2019): -1.
Cita MLA (9a ed.)
Kennedy, Sean P., et al. "Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer." Breast Cancer Research, vol. 21, no. 1, 2019, pp. -1.
Precaución: Estas citas no son 100% exactas.